CCRB Logo

Trial History Detail on 2005-09-12

CUHK_CCT00063

2005-09-12

Retrospective

N/A

Roche

Benny Fok

bfok@cuhk.edu.hk

email

Brian Tomlinson

btomlinson@cuhk.edu.hk

email

A placebo controlled, randomized study to examine the impact of 24-week orlistat treatment on postprandial triglyceridaemia, steatohepatitis and cardiovascular risk factors in overweight Chinese patients

Yes

2003-11-04

Obesity

Drug

Orlistat

24 weeks

Placebo

Chinese patients with obesity and dyslipidaemia

Randomized

Placebo

Double-blind

Parallel

2004-01-01

40

Not Yet Recruiting

Postprandial triglyceridaemia, visceral and hepatic fat deposition

Body weight, cardiovascular risk profiles

No

2009-11-27


Yes

Type Access Document Published On  
No documents yet.
  • Page 1 of 1.